RPL24P7: A Promising Drug Target / Biomarker (G100270963)

Target Name: RPL24P7

NCBI ID: G100270963

RPL24P7

Other Name(s): RPL24_2_348 | RPL24 pseudogene 7 | Ribosomal protein L24 pseudogene 7

RPL24P7: A Promising Drug Target / Biomarker

RPL24P7 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is Rpl24p7, which stands for reticuloplasmic protein 24p7. It is a protein that is composed of 21 amino acids and has a molecular weight of 24.3 kDa. RPL24P7 is involved in a variety of cellular processes in the body, including cell signaling, DNA replication, and repair.

The Importance of RPL24P7

RPL24P7 plays a critical role in the regulation of DNA replication in the cell. During DNA replication, RPL24P7 is involved in the formation of a double helix, which is the foundation of DNA replication.

RPL24P7 is also involved in the repair of DNA damage. When DNA damage occurs, RPL24P7 helps to repair the damage by interacting with the DNA damage repair machinery.

Diseases associated with RPL24P7

RPL24P7 is also associated with a number of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Cancer

RPL24P7 is often expressed in various types of cancer, including breast cancer, ovarian cancer, and prostate cancer. It is thought to play a role in the development and progression of these cancers by contributing to the formation of cancer cells, the growth and spread of cancer cells, and the development of cancer-induced immune evasion.

Neurodegenerative Diseases

RPL24P7 is also involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. These conditions are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles and neuroinclusions.

Autoimmune Diseases

RPL24P7 is also associated with the development of autoimmune diseases, including rheumatoid arthritis, lupus, and multiple sclerosis. These conditions are characterized by the immune system attacking the body's own tissues and causing inflammation and damage.

Molecular Mechanisms

The exact mechanism of how RPL24P7 contributes to these diseases is not fully understood. However, it is thought to participate in a variety of signaling pathways that are involved in the development and progression of these conditions.

Conclusion

RPL24P7 is a protein that is involved in a variety of cellular processes in the body, including cell signaling, DNA replication, and repair. It is also associated with a number of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Further research is needed to fully understand the role of RPL24P7 in these conditions and to develop effective treatments.

Protein Name: RPL24 Pseudogene 7

The "RPL24P7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPL24P7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets